Drug Shortage Report for TRULICITY
Report ID | 145857 |
Drug Identification Number | 02448602 |
Brand name | TRULICITY |
Common or Proper name | DULAGLUTIDE |
Company Name | ELI LILLY CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | DULAGLUTIDE |
Strength(s) | 1.5MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 4 x 0.5 ml single-use prefilled pen |
ATC code | A10BJ |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2021-10-07 |
Actual start date | |
Estimated end date | |
Actual end date | 2021-10-06 |
Shortage status | Avoided shortage |
Updated date | 2021-10-06 |
Company comments | Please contact Eli Lilly Canada's Response Centre 1-888-545-5972 should you have any questions (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays) |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | EXCHANGE TOWER, 130 KING STREET WEST TORONTO, ONTARIO CANADA M5X 1B1 |
Company contact information | Lilly Canada’s Customer Response Centre 1-888-545-5972. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2021-10-06 | French | Compare |
v7 | 2021-10-06 | English | Compare |
v6 | 2021-10-05 | French | Compare |
v5 | 2021-10-05 | English | Compare |
v4 | 2021-09-23 | French | Compare |
v3 | 2021-09-23 | English | Compare |
v2 | 2021-09-17 | French | Compare |
v1 | 2021-09-17 | English | Compare |
Showing 1 to 8 of 8